CD57 and KLRG1 are commonly used as senescence markers in CD4+ and CD8+ T cells to assess T cells fitness after Ebola vaccination [40], in cancer [41] or autoimmunity [42], but their relevance in Tregs is not well defined. The gene discussed is KLRG1; the disease is cancer.